Most of the federal contracts with companies involved in the crash program to make COVID-19 vaccines haven't been made public. The lack of disclosure raises questions about accountability.
"It's the dehumanizing rhetoric President Trump uses when referring to immigrants" that drove Lourdes Vázquez to become a U.S. citizen and to vote in this election for the first time, she says.
The "No Home Birth" policy was created to reduce maternal and newborn mortality rates. But critics say it makes giving birth expensive and complicated — especially during the coronavirus crisis.
Answers to your COVID-19 questions about how to handle Halloween trick-or-treaters, whether it's safe to eat in a restaurant's outdoor bubble and whether you can be infected through your ear canal.
A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.
At a series of listening sessions, participants voiced worries that the development of a COVID-19 vaccine is being politicized and rushed. Public health experts are taking vaccine hesitancy seriously.
The housing market is on a tear, setting all kinds of records, including prices. But it's also a reflection of the uneven economic recovery and more first-time homebuyers are getting priced out.
The U.S. Food and Drug Administration has approved the first drug to treat COVID-19. Remdesivir is an antiviral medicine given through an IV for patients needing hospitalization.
Europe has been battling rising case counts, setting a record last week for new cases reported. Spain and France surpassed the 1 million case mark within hours of each other.
The CARES Act provides funds to pay medical bills for uninsured COVID-19 patients. But a young man's death in Nashville, Tenn., shows people often don't know about the program until it's too late.
As COVID-19 cases increase, many rural communities, places which were largely spared during the early months of the pandemic, are now contending with a spike in infections and hospitalizations.
Pharmaceutical company Moderna on Thursday announced 30,000 volunteers have enrolled in the Phase 3 clinical trial of their COVID-19 vaccine, a huge step toward getting a vaccine to the public. And to hit their goal, the company had to enroll a representative number of people of color, something which for good historical reasons is not always easy to do. But as GPB's Ellen Eldridge reports, Atlanta is helping this vaccine trial buck that trend.
Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.
The witchcraft capital of the U.S. usually courts October visitors but is worried about the coronavirus this year. Officials are taking steps to repel out-of-town goblins.
Being a probate judge in Georgia has turned into a vulnerability during the pandemic.
Fifteen of these Georgia judges — about 1 in 10 – have been infected with COVID-19. And this week, Karen Batten, 62, probate judge of Brantley County, became the third to die of COVID-19.
The state has 159 counties, with a probate judge in each.